Trial intelligence / Profile preview

Optimal FiO2 and ORi for Hyperoxemia Prevention in Children

NCT05505032Phase 4Completed

Sponsor
Baskent University Ankara Hospital
Start
Aug 2022
Primary completion
Sep 2022
Modality
Inhalation Devices
Countries
1
01

Overview

A Phase 4 trial of oxygen in hypoxemia, sponsored by Baskent University Ankara Hospital. Started Aug 2022; status: completed.

02

Drugs

oxygen
03

Conditions

hypoxemia

Beyond the preview

Go deeper on NCT05505032.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05505032.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call